Skip to main content
Clinical Trials/NCT04985370
NCT04985370SuspendedNot Applicable

Pain Neuroscience Education Plus Exercise Versus Exercise Alone in the Management of Chronic Rotator Cuff Tendinopathy: a Randomized Controlled Trial

Ruben Fernandez Matias2 sites in 1 country52 target enrollmentStarted: July 25, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Suspended
Sponsor
Enrollment
52
Locations
2
Primary Endpoint
Change in pain intensity

Study Overview

Brief Summary

The aim of this randomized controlled trial is to evaluate the combined effects of pain neuroscience education plus exercise to exercise alone in the management of patients with chronic rotator cuff tendinopathy regarding pain, function, strength, kinesiophobia, and pain catastrophizing.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Masking Description

Researchers involved in recording outcome measures will not be aware of treatment allocation. Patients will be encouraged to not tell the evaluators about the received treatment.

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Shoulder pain due to rotator cuff tendinopathy lasting more than 6 months.
  • Internal Rotation Resisted Strength Test positive.
  • Test Item Cluster (Hawkins-Kennedy, painful arc, and infraspinatus test) positive.

Exclusion Criteria

  • History of: tumors, metastasis, osteoporosis, shoulder fractures, shoulder luxation and/or instability, previous shoulder surgery, cervical radiculopathy, full-thickness rotator cuff tears, glenohumeral joint degeneration, inflammatory arthropathy, acromioclavicular joint arthrosis, and rotator cuff calcifications.
  • Being treated by other physical therapy or medical treatment for their shoulder pain at the time of recruitment.

Outcomes

Primary Outcomes

Change in pain intensity

Time Frame: Baseline, change from baseline at 4-week, and change from baseline at 12-week

Pain intensity measured with numerical pain rating scale which ranges from 0 points (no pain) to 10 points (worst imaginable pain)

Secondary Outcomes

  • Catastrophism change(Baseline, change from baseline at 4-week, and change from baseline at 12-week)
  • Shoulder disability change(Baseline, change from baseline at 4-week, and change from baseline at 12-week)
  • Kinesiophobia change(Baseline, change from baseline at 4-week, and change from baseline at 12-week)
  • Strength change(Baseline, change from baseline at 4-week, and change from baseline at 12-week)

Investigators

Sponsor
Ruben Fernandez Matias
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Ruben Fernandez Matias

Clinical Professor

University of Alcala

Study Sites (2)

Loading locations...

Similar Trials